A novel algorithm based on left atrial strain parameters in patients with non-valvular atrial fibrillation could

Bo Su1, Junyu Zhao1, Xinjia Dai1

  • 1Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.

Insights

New left atrial strain parameters show promise in identifying cardioembolic risk in atrial fibrillation (AF) patients. A novel algorithm using these parameters accurately predicts risk, even in those with low CHA2DS2-VASc scores.

Area of Science:

  • Cardiology
  • Echocardiography
  • Medical Imaging

Background:

  • Cardioembolic risk stratification in atrial fibrillation (AF) requires improved methods, particularly for patients with lower CHA2DS2-VASc scores.
  • The incremental value of novel left atrial (LA) strain parameters in assessing this risk is not well-established.

Purpose of the Study:

  • To evaluate the role of derived LA strain parameters in cardioembolic risk stratification.
  • To develop and validate a new algorithm for improved risk assessment in AF patients.

Main Methods:

  • 566 non-valvular AF patients underwent transesophageal echocardiography.
  • Left atrial appendage (LAA) thrombogenic milieu was assessed, defined by thrombus, spontaneous echo contrast, or sludge.
  • LA strain parameters (LASr, LASRr, etc.) and a novel decision tree algorithm were analyzed.

Main Results:

  • LA strain parameters demonstrated accuracy (AUC: 0.846-0.916) in identifying LAA thrombogenic milieu, outperforming the CHA2DS2-VASc score (0.645).
  • A novel decision tree algorithm integrating LA strain parameters and CHA2DS2-VASc score achieved high accuracy (AUC: 0.930) for risk stratification.
  • The algorithm performed effectively in subgroup analysis for patients with lower CHA2DS2-VASc scores (0-2).

Conclusions:

  • Derived LA strain parameters are non-inferior to conventional metrics for LAA thrombogenic milieu risk stratification in AF.
  • A novel algorithm utilizing LA strain parameters offers accurate identification of cardioembolic risk in AF patients, including those with low CHA2DS2-VASc scores.
Abstract